Related Experiment Video
Updated: Jan 24, 2026
Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
[CME: Dyslipidemia and Cardiovascular Risk in HIV Infected Patients]
Fabian Tschumi1, Silvio D Brugger1, Dominique L Braun1
11 Klinik für Infektiologie und Spitalhygiene, Universitätsspital Zürich.
Insights
Dyslipidemia, a common issue in HIV patients, elevates cardiovascular risk. Both untreated HIV and antiretroviral drugs can negatively impact lipid profiles, requiring careful management.
Area of Science:
- Internal Medicine
- Infectious Diseases
- Cardiology
Background:
- Dyslipidemia is prevalent in patients with human immunodeficiency virus (HIV).
- HIV infection and its treatment, including antiretroviral drugs, can adversely affect lipid profiles.
- Elevated cardiovascular risk is a significant concern in the HIV-infected population.
Purpose of the Study:
- To outline the diagnostic approaches for dyslipidemia in HIV-infected individuals.
- To detail the workup procedures for identifying dyslipidemia in this patient group.
- To describe current treatment strategies for managing dyslipidemia among HIV patients.
Main Methods:
- Review of current medical literature on dyslipidemia and HIV.
- Analysis of the impact of HIV infection on lipid metabolism.
- Evaluation of the effects of antiretroviral therapy on lipid profiles.
Main Results:
- Dyslipidemia is frequently observed in HIV-infected patients.
- Both untreated HIV and antiretroviral medications can cause dyslipidemia.
- Management requires a comprehensive approach to lipid disorders.
Conclusions:
- Effective diagnosis and management of dyslipidemia are crucial for reducing cardiovascular risk in HIV patients.
- Understanding the interplay between HIV, antiretroviral drugs, and lipid metabolism is essential.
- Multifaceted treatment strategies are necessary for optimal patient outcomes.
Abstract:
CME: Dyslipidemia and Cardiovascular Risk in HIV Infected Patients Abstract. Dyslipidemia is a common problem in HIV-infected patients and can contribute to an elevated cardiovascular risk among this patient group. An untreated HIV infection as well as certain antiretroviral drugs can lead to an unfavorable change of the lipid profile. This article describes the diagnosis, work up and treatment of dyslipidemia in HIV-infected patients.
More Related Videos
Related Concept Videos
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:12Relative Risk
01:14Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
01:20Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:27Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...